BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 22, 2010
 |  BC Week In Review  |  Company News  |  Deals

Celldex, TopoTarget deal

Celldex received a $3 million sublicense payment from TopoTarget after TopoTarget's deal earlier this month with Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI, Irvine, Calif.) to...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >